ReviewFrontiers in nephrology2026

Lipoprotein(a): a potential target for the reduction of residual cardiovascular risk in patients with chronic kidney disease.

Leonardo A Sechi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.